(1308) Impact of Medication Therapy Management Services in a Specialty Pharmacy Setting

Objectives: The objective of the study is to Identify barriers of implementing MTM services in a specialty pharmacy workflow, determine the revenue generated from billed services and its feasibility, measure patient satisfaction with provided MTM service, and assess provider acceptance rate.

Methods: A retrospective, observational study will be conducted in adult patients of a health systems-associated specialty pharmacy who are Medi-Cal beneficiaries and qualify for Medi-Cal MTM services which include patients who are using a medication for rheumatoid arthritis, systemic lupus erythematosus, cancer, cystic fibrosis, multiple sclerosis, hemophilia, hepatitis C, and HIV/AIDS. Patients must meet all of the required criteria listed by Medi-Cal to participate in services. Patients are already surveyed by the pharmacy for their satisfaction of provided services annually in January. The primary investigator and co-investigators will pull the results of the completed survey and include those for patients who are Medi-Cal beneficiaries and completed a MTM session. Additionally, data will be pulled from the pharmacy dispensing software or billing software to gather data on the revenue gained from billing Medi-Cal for MTM services. The investigators will gather a list of participants in the MTM services to gather medical record numbers in order to view their electronic medical record to view communications from medical providers and assess if any pharmacist led recommendations were accepted or declined.

Results: Results are still pending, but data will be collected after the collection period, which will include satisfaction surveys and provider’s acceptance of recommendations from the patients’ electronic medical record messages or documentation. The satisfaction surveys will be collected for those that answered pertaining to MTM services. The primary outcomes measured will be the patients’ satisfaction after completing at least one MTM call, and the number of recommendations accepted by providers. The secondary outcome measured will be the revenue generated from billing Medi-Cal for MTM services over the corresponding data collection period.

Statistical analysis will be conducted using Chi-squared Test for the primary endpoints and a one-sample T-test for the secondary endpoints.

Conclusions: The results are still pending.